Rxivist logo

Author: Sivan Gazit

  • ORCiD: http://orcid.org/0000-0001-9875-3550
  • Most recently observed institution: Kahn Sagol Maccabi (KSM) Research & Innovation Center, Maccabi Healthcare Services, Tel Aviv, Israel.

Rankings

  • All-time downloads: 1,358,523 (rank: 11 )
  • Categories:
    • epidemiology: 127,026 (rank: 187 (tie) )
    • health policy: 1,257 (rank: 606 (tie) )
    • infectious diseases: 1,200,868 (rank: 2 )
    • public and global health: 9,120 (rank: 705 (tie) )

Downloads per author, site-wide

Preprints

Comparing SARS-CoV-2 natural immunity to vaccine-induced immunity: reinfections versus breakthrough infections

infectious diseases more details view paper
  • Downloaded 992,858 times
  • Download rankings, all-time:
    • Site-wide: 2
    • In infectious diseases: 1
  • Year to date:
    • Site-wide: 7
  • Since beginning of last month:
    • Site-wide: 24

Correlation of SARS-CoV-2 Breakthrough Infections to Time-from-vaccine; Preliminary Study

epidemiology more details view paper
  • Downloaded 125,485 times
  • Download rankings, all-time:
    • Site-wide: 54
    • In epidemiology: 15
  • Year to date:
    • Site-wide: 444
  • Since beginning of last month:
    • Site-wide: 445

Decreased SARS-CoV-2 viral load following vaccination

infectious diseases more details view paper
  • Downloaded 94,110 times
  • Download rankings, all-time:
    • Site-wide: 88
    • In infectious diseases: 31
  • Year to date:
    • Site-wide: 710
  • Since beginning of last month:
    • Site-wide: 1,063

The effectiveness of the first dose of BNT162 b 2 vaccine in reducing SARS-CoV-2 infection 13-24 days after immunization: real-world evidence

infectious diseases more details view paper
  • Downloaded 46,094 times
  • Download rankings, all-time:
    • Site-wide: 207
    • In infectious diseases: 78
  • Year to date:
    • Site-wide: 6,852
  • Since beginning of last month:
    • Site-wide: 7,014

Short Term Reduction in the Odds of Testing Positive for SARS-CoV-2; a Comparison Between Two Doses and Three doses of the BNT162b2 Vaccine

infectious diseases more details view paper
  • Downloaded 23,970 times
  • Download rankings, all-time:
    • Site-wide: 461
    • In infectious diseases: 179
  • Year to date:
    • Site-wide: 500
  • Since beginning of last month:
    • Site-wide: 3,813

Viral loads of Delta-variant SARS-CoV2 breakthrough infections following vaccination and booster with the BNT162b2 vaccine

infectious diseases more details view paper
  • Downloaded 14,405 times
  • Download rankings, all-time:
    • Site-wide: 845
    • In infectious diseases: 291
  • Year to date:
    • Site-wide: 2,262
  • Since beginning of last month:
    • Site-wide: 6,352

Associations of the BNT162b2 COVID-19 vaccine effectiveness with patient age and comorbidities at daily resolution

infectious diseases more details view paper
  • Downloaded 12,865 times
  • Download rankings, all-time:
    • Site-wide: 986
    • In infectious diseases: 322
  • Year to date:
    • Site-wide: 3,949
  • Since beginning of last month:
    • Site-wide: 9,291

SARS-CoV-2 infection risk among unvaccinated is negatively associated with community-level vaccination rates

infectious diseases more details view paper
  • Downloaded 10,347 times
  • Download rankings, all-time:
    • Site-wide: 1,304
    • In infectious diseases: 407
  • Year to date:
    • Site-wide: 6,099
  • Since beginning of last month:
    • Site-wide: 13,168

Vaccination with BNT162b2 reduces transmission of SARS-CoV-2 to household contacts in Israel

infectious diseases more details view paper
  • Downloaded 10,217 times
  • Download rankings, all-time:
    • Site-wide: 1,318
    • In infectious diseases: 416
  • Year to date:
    • Site-wide: 2,282
  • Since beginning of last month:
    • Site-wide: 3,098

Relative Effectiveness of Four Doses Compared to Three Dose of the BNT162b2 Vaccine in Israel

public and global health more details view paper
  • Downloaded 5,559 times
  • Download rankings, all-time:
    • Site-wide: 2,959
    • In public and global health: 118
  • Year to date:
    • Site-wide: 283
  • Since beginning of last month:
    • Site-wide: 3,247

A 1 to 1000 SARS-CoV-2 reinfection proportion in members of a large healthcare provider in Israel: a preliminary report

infectious diseases more details view paper
  • Downloaded 4,501 times
  • Download rankings, all-time:
    • Site-wide: 3,925
    • In infectious diseases: 875
  • Year to date:
    • Site-wide: 2,586
  • Since beginning of last month:
    • Site-wide: 33,292

Waning of SARS-CoV-2 booster viral-load reduction effectiveness

infectious diseases more details view paper
  • Downloaded 4,104 times
  • Download rankings, all-time:
    • Site-wide: 4,488
    • In infectious diseases: 949
  • Year to date:
    • Site-wide: 662
  • Since beginning of last month:
    • Site-wide: 60,770

Self-reported and physiological reactions to the third BNT162b2 mRNA COVID-19 (booster) vaccine dose

infectious diseases more details view paper
  • Downloaded 2,555 times
  • Download rankings, all-time:
    • Site-wide: 8,995
    • In infectious diseases: 1,529
  • Year to date:
    • Site-wide: 3,741
  • Since beginning of last month:
    • Site-wide: 27,523

Waning Effectiveness of the BNT162b2 Vaccine Against Infection in Adolescents

epidemiology more details view paper
  • Downloaded 2,239 times
  • Download rankings, all-time:
    • Site-wide: 10,968
    • In epidemiology: 880
  • Year to date:
    • Site-wide: 985
  • Since beginning of last month:
    • Site-wide: 25,941

Waning Effectiveness of the Third Dose of the BNT162b2 mRNA COVID-19 Vaccine

public and global health more details view paper
  • Downloaded 2,129 times
  • Download rankings, all-time:
    • Site-wide: 11,879
    • In public and global health: 309
  • Year to date:
    • Site-wide: 1,076
  • Since beginning of last month:
    • Site-wide: 65,872

Naturally-acquired Immunity Dynamics against SARS-CoV-2 in Children and Adolescents

public and global health more details view paper
  • Downloaded 1,850 times
  • Download rankings, all-time:
    • Site-wide: 14,668
    • In public and global health: 369
  • Year to date:
    • Site-wide: 1,317
  • Since beginning of last month:
    • Site-wide: 36,176

Survey of Behaviour Attitudes Towards Preventive Measures Following COVID-19 Vaccination

health policy more details view paper
  • Downloaded 1,296 times
  • Download rankings, all-time:
    • Site-wide: 25,680
    • In health policy: 81
  • Year to date:
    • Site-wide: 14,647
  • Since beginning of last month:
    • Site-wide: 99,126

BNT162b2 mRNA Vaccine Effectiveness Given Confirmed Exposure; Analysis of Household Members of COVID-19 Patients

infectious diseases more details view paper
  • Downloaded 1,204 times
  • Download rankings, all-time:
    • Site-wide: 28,822
    • In infectious diseases: 2,742
  • Year to date:
    • Site-wide: 53,463
  • Since beginning of last month:
    • Site-wide: 74,679

Kinetics of SARS-CoV-2 anti-s IgG after BNT162b2 vaccination

infectious diseases more details view paper
  • Downloaded 1,186 times
  • Download rankings, all-time:
    • Site-wide: 29,504
    • In infectious diseases: 2,768
  • Year to date:
    • Site-wide: 52,290
  • Since beginning of last month:
    • Site-wide: 176,567

Safety of the fourth COVID-19 BNT162b2 mRNA (second booster) vaccine

infectious diseases more details view paper
  • Downloaded 832 times
  • Download rankings, all-time:
    • Site-wide: 50,900
    • In infectious diseases: 4,043
  • Year to date:
    • Site-wide: 4,614
  • Since beginning of last month:
    • Site-wide: 13,010

A Multilayer Model for Early Detection of COVID-19

infectious diseases more details view paper
  • Downloaded 420 times
  • Download rankings, all-time:
    • Site-wide: 119,649
    • In infectious diseases: 5,855
  • Year to date:
    • Site-wide: 53,477
  • Since beginning of last month:
    • Site-wide: 178,731

Immunosuppression as a hub for SARS-CoV-2 mutational drift

epidemiology more details view paper
  • Downloaded 297 times
  • Download rankings, all-time:
    • Site-wide: 155,360
    • In epidemiology: 6,267
  • Year to date:
    • Site-wide: 25,211
  • Since beginning of last month:
    • Site-wide: 129,212

PanLingua

News